Is concomitant use of bupropion (Wellbutrin) and escitalopram (Lexapro) safe, and what is the recommended dosing regimen?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 4, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Combining Wellbutrin (Bupropion) with Lexapro (Escitalopram)

The combination of bupropion and escitalopram is safe and commonly used in clinical practice, with FDA drug labeling explicitly acknowledging this combination and research demonstrating good tolerability and potential efficacy benefits. 1

Safety Profile

The combination is generally well-tolerated with manageable side effects:

  • Bupropion inhibits CYP2D6, which can increase escitalopram levels, though escitalopram has the least effect on CYP450 enzymes compared to other SSRIs and lower propensity for drug interactions 1, 2
  • When combining these medications, consider starting escitalopram at standard doses (10-20 mg daily) and monitoring for increased effects, though dose reduction is typically not required since escitalopram is not heavily metabolized by CYP2D6 1
  • Serotonin syndrome risk is low with this combination, as bupropion has no serotonergic activity—caution is primarily needed when combining multiple serotonergic agents 2
  • Seizure risk remains at baseline 0.1% with bupropion at doses ≤450 mg/day; avoid in patients with seizure disorders, brain metastases, eating disorders, or abrupt alcohol/benzodiazepine discontinuation 1, 2

Dosing Regimen

Standard approach for combination therapy:

  • Escitalopram: 10-20 mg once daily (maximum 20 mg/day) 2
  • Bupropion XL: Start 150 mg once daily for 3-7 days, then increase to 150 mg twice daily or 300 mg once daily (maximum 450 mg/day) 1
  • No specific dose adjustments are required when combining, though monitoring for enhanced effects is prudent 1

Clinical Evidence for Combination Use

The combination shows promise for treatment-resistant depression:

  • Open-label studies demonstrate 50-62% remission rates when combining escitalopram and bupropion, higher than typical SSRI monotherapy rates of 30-35% 3, 4
  • One optimized-dose study (escitalopram up to 40 mg, bupropion up to 450 mg) showed superior early remission at week 2 (18% vs 0% for monotherapies) and maintained advantages through 12 weeks 4
  • However, the largest randomized controlled trial (n=245) found no significant advantage of initial combination therapy over monotherapy in speed or rate of remission 5
  • Augmentation studies show adding bupropion to escitalopram in non-responders produces additional remissions, with combination superior to switching strategies 6

Specific Clinical Scenarios

When to preferentially use this combination:

  • Treatment-resistant depression after SSRI monotherapy failure: Augmentation with bupropion is a validated strategy 2, 7
  • SSRI-associated sexual dysfunction: Bupropion effectively reverses antidepressant-induced sexual side effects 7
  • Patients concerned about weight gain: Bupropion is associated with weight loss (-0.22 kg at 6 months) compared to escitalopram's modest weight gain (0.41 kg) 8
  • Comorbid smoking cessation needs: Bupropion provides dual benefit for depression and smoking cessation 2

Monitoring Requirements

Key parameters to track:

  • Blood pressure monitoring: Both medications can increase blood pressure; bupropion requires baseline and periodic monitoring 1
  • Neuropsychiatric symptoms: Monitor for worsening depression, suicidal ideation, agitation, or hostility, particularly in first 24-48 hours after dose changes 1, 2
  • Seizure precautions: Avoid doses >450 mg/day bupropion; use extreme caution with other seizure threshold-lowering drugs 1

Important Contraindications and Cautions

Absolute contraindications for bupropion:

  • Seizure disorder or conditions increasing seizure risk 1
  • Current or prior bulimia or anorexia nervosa 1
  • Abrupt discontinuation of alcohol, benzodiazepines, or antiepileptics 1
  • Concurrent MAOI use (14-day washout required) 1

Relative cautions:

  • Hepatic impairment: Reduce bupropion to 150 mg every other day in moderate-severe impairment 1
  • Renal impairment: Consider dose/frequency reduction for both medications 1
  • Bipolar disorder screening: Both medications can precipitate mania; screen before initiating 1, 2

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.